- Home
- SUPN vs BTDR Comparison
SUPN vs BTDR Comparison
Compare SUPN & BTDR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SUPN
- BTDR
- Stock Information
- Founded
- SUPN 2005
- BTDR 2021
- Country
- SUPN United States
- BTDR Singapore
- Employees
- SUPN N/A
- BTDR N/A
- Industry
- SUPN Biotechnology: Pharmaceutical Preparations
- BTDR EDP Services
- Sector
- SUPN Health Care
- BTDR Technology
- Exchange
- SUPN Nasdaq
- BTDR Nasdaq
- Market Cap
- SUPN 2.6B
- BTDR 2.6B
- IPO Year
- SUPN 2012
- BTDR N/A
- Fundamental
- Price
- SUPN $46.21
- BTDR $13.64
- Analyst Decision
- SUPN Buy
- BTDR Strong Buy
- Analyst Count
- SUPN 2
- BTDR 9
- Target Price
- SUPN $43.00
- BTDR $20.61
- AVG Volume (30 Days)
- SUPN 707.2K
- BTDR 3.9M
- Earning Date
- SUPN 11-03-2025
- BTDR 08-18-2025
- Dividend Yield
- SUPN N/A
- BTDR N/A
- EPS Growth
- SUPN 1411.53
- BTDR N/A
- EPS
- SUPN 1.14
- BTDR N/A
- Revenue
- SUPN $665,125,000.00
- BTDR $356,757,000.00
- Revenue This Year
- SUPN $4.84
- BTDR $64.87
- Revenue Next Year
- SUPN $17.69
- BTDR $89.53
- P/E Ratio
- SUPN $40.24
- BTDR N/A
- Revenue Growth
- SUPN 5.55
- BTDR N/A
- 52 Week Low
- SUPN $29.16
- BTDR $5.62
- 52 Week High
- SUPN $46.79
- BTDR $26.99
- Technical
- Relative Strength Index (RSI)
- SUPN 73.71
- BTDR 52.78
- Support Level
- SUPN $44.10
- BTDR $11.85
- Resistance Level
- SUPN $46.79
- BTDR $14.71
- Average True Range (ATR)
- SUPN 1.06
- BTDR 0.99
- MACD
- SUPN -0.17
- BTDR 0.00
- Stochastic Oscillator
- SUPN 85.92
- BTDR 62.59
About SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.
About BTDR Bitdeer Technologies Group
Bitdeer Technologies Group is principally engaged in provision of digital asset mining services. The Company does not conduct any substantive operations on its own but conducts its primary operations through its subsidiaries. Its majority business segments are: proprietary mining, cloud hash rate sharing and cloud hosting. The company operates five proprietary mining datacenters in the United States and Norway, Bhutan and Singapore.